Literature DB >> 31938261

Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease.

Zejian Li1, Chunting Lu2,3, Jiayu Qiu1, Shengwen Liu1, Xiaoqi Liu1, Shuyuan Ma1, Renfa Lai1.   

Abstract

OBJECTIVE: To analyze the correlation of serum levels of visfatin, leptin, resistin, and adiponectin (APN) with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease.
METHODS: 116 obese adults (OB), of whom 78 participants were diagnosed with different degrees of chronic periodontitis (CP), and 50 healthy adults were recruited into the study. Fasting peripheral venous blood was extracted to determine serum levels of adipocytokines (e.g., visfatin, leptin, resistin, and APN), glucolipid metabolism (e.g., fasting blood glucose (FBG), fasting insulin (FINS), C-peptide (C-P), cortisol (Cor), homeostasis model of assessment for insulin resistance index (HOMA-IR), glycosylated hemoglobin (HbA1c), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and non-high-density lipoprotein cholesterol (non-HDL)), and micro-inflammation-related indexes like C-reactive protein (CRP), interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor (TNF)-α. Correlation between levels of adipocytokines and levels of glucolipid metabolism and inflammatory factors was further analyzed.
RESULTS: Assays for plasma levels of adipocytokines showed that both the OB group and the OB with CP group had significantly higher serum levels of visfatin, leptin, and resistin than the normal control group and significantly lower serum levels of ANP than the normal control group (P<0.05). Detection of serum glucolipid metabolism levels showed that FBG, FINS, C-P, Cor, HOMA-IR, TG, TC, LDL-C, HDL-C, Non-HDL-C of OB group, and OB with CP patients were significantly higher than those of normal patients (P<0.05). Assay for plasma levels of inflammatory factors showed that both the OB group and the OB with CP group had significantly higher serum levels of CRP, IL-1β, IL-6, and TNF-α than the normal control group and significantly lower serum levels of IL-10 than the normal control group. Spearman's correlation analysis revealed that serum levels of visfatin, leptin, resistin, and APN were significantly correlated with concentrations of FBG, FINS, C-P, Cor, TG, TC, LDL-C, HDL-C, Non-HDL-C, CRP, IL-1β, IL-6, IL-10, and TNF-α.
CONCLUSIONS: There were high expression levels of inflammatory factors and glucolipid metabolism disorder in obese patients with periodontal disease and excessively expressed adipocytokines may be important factors of persistent and worsened obesity and of periodontitis. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Obese; adipocytokines; chronic periodontitis; glycolipid metabolism; inflammatory factors

Year:  2018        PMID: 31938261      PMCID: PMC6958146     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

Review 1.  Periodontal diagnoses and classification of periodontal diseases.

Authors:  Gary C Armitage
Journal:  Periodontol 2000       Date:  2004       Impact factor: 7.589

2.  Usefulness of the conicity index together with the conjoint use of adipocytokines and nutritional-inflammatory markers in hemodialysis patients.

Authors:  Mar Ruperto; Guillermina Barril; Francisco J Sánchez-Muniz
Journal:  J Physiol Biochem       Date:  2016-10-13       Impact factor: 4.158

3.  Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.

Authors:  Iain L C Chapple; Robert Genco
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

Review 4.  Periodontitis in systemic rheumatic diseases.

Authors:  Paola de Pablo; Iain L C Chapple; Christopher D Buckley; Thomas Dietrich
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

5.  Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Authors:  Michel P Hermans; Frank M Sacks; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2011-02-28       Impact factor: 9.951

6.  Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

Authors:  Resul Kahraman; Turan Calhan; Abdurrahman Sahin; Kamil Ozdil; Zuhal Caliskan; Elif Sinem Bireller; Bedia Cakmakoglu
Journal:  Ther Clin Risk Manag       Date:  2017-09-30       Impact factor: 2.423

7.  Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Authors:  Huimin Dong; Yang Xu; Xiuzhi Zhang; Simiao Tian
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

8.  Adiponectin, leptin and TNF-α serum levels in obese and normal weight Peruvian adults with and without chronic periodontitis.

Authors:  Gerardo Mendoza-Azpur; Carmen Castro; Lizet Peña; Maria-Eugenia Guerrero; Manuel De La Rosa; Claudio Mendes; Leandro Chambrone
Journal:  J Clin Exp Dent       Date:  2015-07-01

Review 9.  Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis.

Authors:  Archana Devanoorkar; Rahul Kathariya; Nagappa Guttiganur; D Gopalakrishnan; Paulami Bagchi
Journal:  Dis Markers       Date:  2014-02-12       Impact factor: 3.434

10.  Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Authors:  Vincent Blasco-Baque; Lucile Garidou; Céline Pomié; Quentin Escoula; Pascale Loubieres; Sandrine Le Gall-David; Mathieu Lemaitre; Simon Nicolas; Pascale Klopp; Aurélie Waget; Vincent Azalbert; André Colom; Martine Bonnaure-Mallet; Philippe Kemoun; Matteo Serino; Rémy Burcelin
Journal:  Gut       Date:  2016-02-02       Impact factor: 23.059

View more
  1 in total

1.  Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?

Authors:  Esra Sinem Kemer Doğan; Nizami Duran
Journal:  Clin Oral Investig       Date:  2022-04-22       Impact factor: 3.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.